Chemical Formula: C16H23NO7

Chemical Formula C16H23NO7

Found 16 metabolite its formula value is C16H23NO7

Mycotoxin T 2

N-({4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}methyl)ethoxycarboximidate

C16H23NO7 (341.1474)


Isolated from seed pods of Moringa oleifera (horseradish tree). Mycotoxin T 2 is found in fats and oils, herbs and spices, and green vegetables. Mycotoxin T 2 is found in fats and oils. Mycotoxin T 2 is a mycotoxin T 2 is isolated from seed pods of Moringa oleifera (horseradish tree)

   

NCGC00385937-01

NCGC00385937-01

C16H23NO7 (341.1474)


   

Monocrotaline N-Oxide

5,6-dihydroxy-4,5,6-trimethyl-13-oxido-2,8-dioxa-13-azoniatricyclo[8.5.1.013,16]hexadec-10-ene-3,7-dione

C16H23NO7 (341.1474)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 173 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 163 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 153 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 143 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 133 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 123 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 113 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 103 INTERNAL_ID 103; CONFIDENCE Reference Standard (Level 1)

   

N-acetyltyramine 1-O-beta-glucoside

N-acetyltyramine 1-O-beta-glucoside

C16H23NO7 (341.1474)


   

6,7-dihydroxy-1-methyl-N-(6-fructopyranosyl)-1,2,3,4-tetrahydroisoquinoline

6,7-dihydroxy-1-methyl-N-(6-fructopyranosyl)-1,2,3,4-tetrahydroisoquinoline

C16H23NO7 (341.1474)


   

Monocrotaline N-Oxide

(1R,4R,5R,6R,16R)-5,6-dihydroxy-4,5,6-trimethyl-13-oxido-2,8-dioxa-13-azoniatricyclo[8.5.1.013,16]hexadec-10-ene-3,7-dione

C16H23NO7 (341.1474)


Monocrotaline N-Oxide, a monocrotaline metabolite, leads to DNA adduct formation in vivo. Monocrotaline N-Oxide is a derivative of monocrotaline, which is a pyrrolizidine alkaloid. Pyrrolizidine alkaloids are a class of naturally occurring compounds found in various plants. Monocrotaline itself is known for its toxic effects, particularly its ability to cause liver damage and pulmonary hypertension in animals. The biological functions and effects of Monocrotaline N-Oxide are primarily studied in the context of its toxicology and pharmacology: Metabolic Activation: Monocrotaline N-Oxide is a metabolite of monocrotaline. In biological systems, monocrotaline is metabolized to its N-oxide form, which can then be further converted into reactive intermediates that can form DNA adducts, leading to potential mutagenicity and carcinogenicity. Toxicity: Like monocrotaline, Monocrotaline N-Oxide is toxic, particularly to the liver and lungs. It can induce pulmonary hypertension, a condition characterized by increased blood pressure in the arteries of the lungs. This makes it useful in animal models to study the pathophysiology of this disease. Research Tool: Due to its toxic effects, Monocrotaline N-Oxide is used in research as a tool to investigate the mechanisms of toxin-induced liver and lung damage, as well as to study the biological pathways involved in the metabolism and detoxification of pyrrolizidine alkaloids. Potential Therapeutic Uses: Although highly toxic, monocrotaline and its derivatives have been studied for their potential therapeutic uses, particularly in the context of cancer treatment, due to their ability to damage rapidly dividing cells. Ecological Role: In nature, pyrrolizidine alkaloids like monocrotaline may serve as defense mechanisms for plants, deterring herbivory due to their toxic properties. It's important to note that while Monocrotaline N-Oxide has significant biological effects, its use is largely restricted to research settings due to its toxicity. Handling and use of this compound require strict safety precautions to prevent exposure and adverse health effects.

   

C16H23NO7_2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione, 4,5,8,10,12,13,13a,13b-octahydro-3,4-dihydroxy-3,4,5-trimethyl-, 11-oxide

NCGC00385937-01_C16H23NO7_2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione, 4,5,8,10,12,13,13a,13b-octahydro-3,4-dihydroxy-3,4,5-trimethyl-, 11-oxide

C16H23NO7 (341.1474)


   

(4S,5Z,6S)-4-(2-methoxy-2-oxoethyl)-5-[2-[(E)-3-phenylprop-2-enoyl]oxyethylidene]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid

(4S,5Z,6S)-4-(2-methoxy-2-oxoethyl)-5-[2-[(E)-3-phenylprop-2-enoyl]oxyethylidene]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid

C16H23NO7 (341.1474)


   

Mycotoxin T 2

ethyl N-({4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}methyl)carbamate

C16H23NO7 (341.1474)


   

Z-D-Asp(OtBu)-OH.H2O

Z-D-Asp(OtBu)-OH.H2O

C16H23NO7 (341.1474)


   

Phendimetrazine tartrate

Phendimetrazine tartrate

C16H23NO7 (341.1474)


D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant C78272 - Agent Affecting Nervous System > C29728 - Anorexiant

   

n-({4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}methyl)ethoxycarboximidic acid

n-({4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}methyl)ethoxycarboximidic acid

C16H23NO7 (341.1474)


   

6,7-dihydroxy-1-methyl-n-(6'-fructopyranosyl)-1,2,3,4-tetrahydroisoquinoline

NA

C16H23NO7 (341.1474)


{"Ingredient_id": "HBIN012063","Ingredient_name": "6,7-dihydroxy-1-methyl-n-(6'-fructopyranosyl)-1,2,3,4-tetrahydroisoquinoline","Alias": "NA","Ingredient_formula": "C16H23NO7","Ingredient_Smile": "CC1C2=CC(=C(C=C2CCN1C3(C(C(C(CO3)O)O)O)CO)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6032","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

n-[2-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethyl]ethanimidic acid

n-[2-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethyl]ethanimidic acid

C16H23NO7 (341.1474)


   

n-[(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)methyl]ethoxycarboximidic acid

n-[(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)methyl]ethoxycarboximidic acid

C16H23NO7 (341.1474)


   

n-[2-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethyl]ethanimidic acid

n-[2-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethyl]ethanimidic acid

C16H23NO7 (341.1474)